1. Home
  2. MDXG vs NVGS Comparison

MDXG vs NVGS Comparison

Compare MDXG & NVGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • NVGS
  • Stock Information
  • Founded
  • MDXG 2006
  • NVGS 1997
  • Country
  • MDXG United States
  • NVGS United Kingdom
  • Employees
  • MDXG N/A
  • NVGS N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • NVGS Marine Transportation
  • Sector
  • MDXG Health Care
  • NVGS Consumer Discretionary
  • Exchange
  • MDXG Nasdaq
  • NVGS Nasdaq
  • Market Cap
  • MDXG 1.1B
  • NVGS 1.1B
  • IPO Year
  • MDXG N/A
  • NVGS N/A
  • Fundamental
  • Price
  • MDXG $6.94
  • NVGS $16.54
  • Analyst Decision
  • MDXG Buy
  • NVGS Strong Buy
  • Analyst Count
  • MDXG 1
  • NVGS 2
  • Target Price
  • MDXG $12.00
  • NVGS $21.50
  • AVG Volume (30 Days)
  • MDXG 430.1K
  • NVGS 286.2K
  • Earning Date
  • MDXG 10-29-2025
  • NVGS 11-05-2025
  • Dividend Yield
  • MDXG N/A
  • NVGS 1.21%
  • EPS Growth
  • MDXG N/A
  • NVGS 12.51
  • EPS
  • MDXG 0.21
  • NVGS 1.26
  • Revenue
  • MDXG $363,774,000.00
  • NVGS $566,889,000.00
  • Revenue This Year
  • MDXG $12.68
  • NVGS $2.20
  • Revenue Next Year
  • MDXG $8.18
  • NVGS N/A
  • P/E Ratio
  • MDXG $33.06
  • NVGS $13.13
  • Revenue Growth
  • MDXG 6.85
  • NVGS 1.19
  • 52 Week Low
  • MDXG $5.47
  • NVGS $10.55
  • 52 Week High
  • MDXG $10.14
  • NVGS $17.53
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.16
  • NVGS 59.50
  • Support Level
  • MDXG $6.81
  • NVGS $16.27
  • Resistance Level
  • MDXG $7.14
  • NVGS $16.77
  • Average True Range (ATR)
  • MDXG 0.19
  • NVGS 0.29
  • MACD
  • MDXG -0.04
  • NVGS 0.02
  • Stochastic Oscillator
  • MDXG 26.53
  • NVGS 74.16

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About NVGS Navigator Holdings Ltd. (Marshall Islands)

Navigator Holdings Ltd owns and operates liquefied gas carriers, which include a fleet of handysize liquefied gas carriers. The company also owns a share in an ethylene export marine terminal at Morgan's Point, Texas on the Houston Ship Channel (the Ethylene Export Terminal) through a joint venture (the Export Terminal Joint Venture). Company play a vital role in theglobalised liquefied gas supply chain, providing gas transportation solutions for energy companies, industrial users and commodity traders.

Share on Social Networks: